Design, Synthesis, and Structure-Activity Relationship Studies of Magnolol Derivatives as Antifungal Agents. 2021

Hu Li, and Ying-Hui He, and Yong-Mei Hu, and Qing-Ru Chu, and Yong-Jia Chen, and Zhen-Rong Wu, and Zhi-Jun Zhang, and Ying-Qian Liu, and Cheng-Jie Yang, and Hong-Jie Liang, and Yin-Fang Yan
School of Pharmacy, Lanzhou University, Lanzhou 730000, People's Republic of China.

Plant pathogenic fungi seriously affect agricultural production and are difficult to control. The discovery of new leads based on natural products is an important way to innovate fungicides. In this study, 30 natural-product-based magnolol derivatives were synthesized and characterized on the basis of NMR and mass spectroscopy. Bioactivity tests on phytopathogenic fungi (Rhizoctonia solani, Fusarium graminearum, Botrytis cinerea, and Sclerotinia sclerotiorum) in vitro of these compounds were performed systematically. The results showed that 11 compounds were active against four kinds of phytopathogenic fungi with EC50 values in the range of 1.40-20.00 μg/mL, especially compound L5 that exhibited excellent antifungal properties against B. cinerea with an EC50 value of 2.86 μg/mL, approximately 2.8-fold more potent than magnolol (EC50 = 8.13 μg/mL). Moreover, compound L6 showed the highest antifungal activity against F. graminearum and Rhophitulus solani with EC50 values of 4.39 and 1.40 μg/mL, respectively, and compound L7 showed good antifungal activity against S. sclerotiorum. Then, an in vivo experiment of compound L5 against B. cinerea was further investigated in vivo using infected tomatoes (curative effect, 50/200 and 36%/100 μg/mL). The physiological and biochemical studies illustrated that the primary action mechanism of compound L5 on B. cinerea might change the mycelium morphology, increase cell membrane permeability, and destroy the function of mitochondria. Furthermore, structure-activity relationship (SAR) studies revealed that hydroxyl groups play a key role in antifungal activity. To sum up, this study provides a reference for understanding the application of magnolol-based antifungal agents in crop protection.

UI MeSH Term Description Entries
D005659 Fungicides, Industrial Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. Industrial Fungicides
D005670 Fusarium A mitosporic Hypocreales fungal genus, various species of which are important parasitic pathogens of plants and a variety of vertebrates. Teleomorphs include GIBBERELLA. Fusariums
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D001203 Ascomycota A phylum of fungi which have cross-walls or septa in the mycelium. The perfect state is characterized by the formation of a saclike cell (ascus) containing ascospores. Most pathogenic fungi with a known perfect state belong to this phylum. Ascomycetes,Cochliobolus,Sclerotinia,Ascomycete,Ascomycotas,Sclerotinias
D001713 Biphenyl Compounds Whitish aromatic crystalline organic compounds made up of two conjoined BENZENE rings. Compounds, Biphenyl
D012232 Rhizoctonia A mitosporic Ceratobasidiaceae fungal genus that is an important plant pathogen affecting potatoes and other plants. There are numerous teleomorphs. Rhizoctonias
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D017705 Lignans A class of dibenzylbutane derivatives which occurs in higher plants and in fluids (bile, serum, urine, etc.) in man and other animals. These compounds, which have a potential anti-cancer role, can be synthesized in vitro by human fecal flora. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Lignan,Neolignan,Neolignans

Related Publications

Hu Li, and Ying-Hui He, and Yong-Mei Hu, and Qing-Ru Chu, and Yong-Jia Chen, and Zhen-Rong Wu, and Zhi-Jun Zhang, and Ying-Qian Liu, and Cheng-Jie Yang, and Hong-Jie Liang, and Yin-Fang Yan
November 2016, European journal of medicinal chemistry,
Hu Li, and Ying-Hui He, and Yong-Mei Hu, and Qing-Ru Chu, and Yong-Jia Chen, and Zhen-Rong Wu, and Zhi-Jun Zhang, and Ying-Qian Liu, and Cheng-Jie Yang, and Hong-Jie Liang, and Yin-Fang Yan
January 2017, Bioorganic & medicinal chemistry,
Hu Li, and Ying-Hui He, and Yong-Mei Hu, and Qing-Ru Chu, and Yong-Jia Chen, and Zhen-Rong Wu, and Zhi-Jun Zhang, and Ying-Qian Liu, and Cheng-Jie Yang, and Hong-Jie Liang, and Yin-Fang Yan
September 2019, European journal of medicinal chemistry,
Hu Li, and Ying-Hui He, and Yong-Mei Hu, and Qing-Ru Chu, and Yong-Jia Chen, and Zhen-Rong Wu, and Zhi-Jun Zhang, and Ying-Qian Liu, and Cheng-Jie Yang, and Hong-Jie Liang, and Yin-Fang Yan
January 2023, Molecules (Basel, Switzerland),
Hu Li, and Ying-Hui He, and Yong-Mei Hu, and Qing-Ru Chu, and Yong-Jia Chen, and Zhen-Rong Wu, and Zhi-Jun Zhang, and Ying-Qian Liu, and Cheng-Jie Yang, and Hong-Jie Liang, and Yin-Fang Yan
June 2023, Antibiotics (Basel, Switzerland),
Hu Li, and Ying-Hui He, and Yong-Mei Hu, and Qing-Ru Chu, and Yong-Jia Chen, and Zhen-Rong Wu, and Zhi-Jun Zhang, and Ying-Qian Liu, and Cheng-Jie Yang, and Hong-Jie Liang, and Yin-Fang Yan
August 2012, European journal of medicinal chemistry,
Hu Li, and Ying-Hui He, and Yong-Mei Hu, and Qing-Ru Chu, and Yong-Jia Chen, and Zhen-Rong Wu, and Zhi-Jun Zhang, and Ying-Qian Liu, and Cheng-Jie Yang, and Hong-Jie Liang, and Yin-Fang Yan
March 2014, International journal of molecular sciences,
Hu Li, and Ying-Hui He, and Yong-Mei Hu, and Qing-Ru Chu, and Yong-Jia Chen, and Zhen-Rong Wu, and Zhi-Jun Zhang, and Ying-Qian Liu, and Cheng-Jie Yang, and Hong-Jie Liang, and Yin-Fang Yan
August 2018, The Journal of antibiotics,
Hu Li, and Ying-Hui He, and Yong-Mei Hu, and Qing-Ru Chu, and Yong-Jia Chen, and Zhen-Rong Wu, and Zhi-Jun Zhang, and Ying-Qian Liu, and Cheng-Jie Yang, and Hong-Jie Liang, and Yin-Fang Yan
June 2014, Journal of medicinal chemistry,
Hu Li, and Ying-Hui He, and Yong-Mei Hu, and Qing-Ru Chu, and Yong-Jia Chen, and Zhen-Rong Wu, and Zhi-Jun Zhang, and Ying-Qian Liu, and Cheng-Jie Yang, and Hong-Jie Liang, and Yin-Fang Yan
March 2013, Journal of natural products,
Copied contents to your clipboard!